ArticleJournal of computer-aided molecular design2026
MMP-9i Predictor v1.0: an integrative machine learning platform for predicting MMP-9 inhibitors using chemical space analysis and explainable models.
Article in Journal of computer-aided molecular design, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The inhibition of MMP-9 has emerged as a promising therapeutic strategy for treating diseases such as cancer, arthritis, and central nervous system disorders. Despite the potential benefits, the development of MMP-9 inhibitors (MMP-9i) has faced significant challenges, particularly concerning selectivity and off-target toxicity. In this context, we performed a comprehensive cheminformatics study (including chemical space analysis and machine learning approaches) to investigate the structural and physicochemical determinants of MMP-9 inhibitory activity, aiming to facilitate the rational design of promising inhibitors. Model interpretability was enhanced through SHAP analysis, which elucidated the contribution of key features. To improve accessibility for the scientific community, we developed the MMP-9i Predictor v1.0 web tool ( https://mmp-9ipredictor.streamlit.app/ ) to enable prospective screening of novel MMP-9i. It also enables a reliable distinction between inhibitors and non-inhibitors and assesses their applicability domains (AD). Additionally, it visualizes input structures in 2D, enhancing interpretability for researchers.
Indexed as
Identifiers
41989610What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.